Trying To Protect Seniors, The Most Vulnerable, From Formidable Foe Florence
By Liz Szabo and JoNel Aleccia and Doug Pardue
September 12, 2018
KFF Health News Original
With Hurricane Florence predicted to slam the Southeast’s coastline Friday, health officials scramble to dodge the storm and keep older residents safe.
How The Shutdown Might Affect Your Health
By KFF Health News Staff
January 19, 2018
KFF Health News Original
For some federal health programs, a shuttered government means business as usual. But the congressional impasse over funding will hit others hard.
Near Incineration Of Psychiatric Hospital Highlights Gaping Need For More Beds
By Barbara Feder Ostrov
December 21, 2017
KFF Health News Original
Fire almost destroyed one of two acute care facilities in Ventura County — wiping out most of the region’s inpatient capacity. In California and nationally, such hospitals are strained by demand — and disasters.
Trump Vows (Again) To Lower Drug Prices But Skeptics Doubt Much Will Change
By Sarah Jane Tribble and Liz Szabo
May 11, 2018
KFF Health News Original
President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
Doing More Harm Than Good? Epidemic of Screening Burdens Nation’s Older Patients
By Liz Szabo
December 20, 2017
KFF Health News Original
Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.
Tanta atención que duele: terapias y cirugías innecesarias agregan dolor y enfermedad
By Liz Szabo
October 23, 2017
KFF Health News Original
Las pruebas excesivas de cáncer de tiroides, próstata, seno y piel lleva a muchas personas mayores a someterse a tratamientos que no prolongarán sus vidas, pero que pueden causar dolor y sufrimiento innecesarios.
So Much Care It Hurts: Unneeded Scans, Therapy, Surgery Only Add To Patients’ Ills
By Liz Szabo
October 23, 2017
KFF Health News Original
Overtreatment of breast cancer and other diseases is pervasive, burdening patients and the health care system with enormous costs and needless suffering.
Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient
By Liz Szabo
October 17, 2017
KFF Health News Original
The costs of using a new class of cancer treatments include far more than the drug’s sticker price.
FDA Head Vows To Tackle High Drug Prices And Drugmakers ‘Gaming The System’
By Sarah Jane Tribble and Liz Szabo
February 15, 2018
KFF Health News Original
In an exclusive interview, FDA Commissioner Scott Gottlieb describes what he’s doing to spur competition and bring down drug prices.
Algunos pacientes con cáncer de tiroides pueden retrasar la cirugía
By Liz Szabo
August 31, 2017
KFF Health News Original
Alrededor de un tercio de los pacientes con un tumor de tiroides de crecimiento lento, llamado cáncer de tiroides papilar, son elegibles para retrasar el tratamiento, según un nuevo estudio.
Some Thyroid Cancer Patients Can Safely Delay Surgery
By Liz Szabo
August 31, 2017
KFF Health News Original
Study suggests that many small tumors are sleepy, not deadly.
Pioneering Cancer Gene Therapy Gets Green Light — And $475,000 Price Tag
By Liz Szabo
August 30, 2017
KFF Health News Original
The USA’s first approved gene therapy — to be used to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment.
First Edition: June 5, 2018
June 5, 2018
Morning Briefing
DID YOU TAKE YOUR VITAMINS? If so, you are one among millions of Americans. But what evidence is there that they ward off chronic disease? Tune in to the next KHN Facebook Live on Wednesday, June 6, at 3 p.m. ET, when senior correspondent Liz Szabo will separate fact from fiction. You can submit your questions and watch here.
Nueva droga contra la leucemia ofrece esperanza, pero a un costo millonario
By Liz Szabo
August 23, 2017
KFF Health News Original
El tratamiento con una nueva droga del laboratorio Novartis para casos en los que ha fracasado la quimioterapia o el trasplante de médula costaría $649,000.
‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost
By Liz Szabo
August 23, 2017
KFF Health News Original
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
Depression Among Heart Attack Survivors Can Be Deadly, Yet Is Often Ignored
By Liz Szabo
July 20, 2017
KFF Health News Original
One in 5 heart attack patients suffers from severe depression, yet many get little or no treatment that could ease their suffering or save their lives.
Senate GOP Bill Aims To Add Psych Beds; Squeeze On Medicaid Signals Their Undoing
By Liz Szabo
July 10, 2017
KFF Health News Original
The Senate health care bill has a provision to increase hospital beds for psychiatric care, but overall cuts in Medicaid could lead to even fewer beds nationwide.
“¿Cuánto tiempo me queda, doctor?” Por qué muchos pacientes con cáncer no obtienen respuestas
By Liz Szabo
June 12, 2017
KFF Health News Original
Muchas veces los pacientes con cáncer no reciben respuestas adecuadas a preguntas críticas, entre ellas, la más crucial y universal de todas.
‘How Long Have I Got, Doc?’ Why Many Cancer Patients Don’t Have Answers
By Liz Szabo
June 12, 2017
KFF Health News Original
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
As Government-Funded Cancer Research Sags, Scientists Fear U.S. Is ‘Losing Its Edge’
By Liz Szabo
June 2, 2017
KFF Health News Original
More of the research studies being presented at the world’s largest annual gathering of cancer scientists comes from abroad.